Collectively, our current findings provided a novel mechanism underlying the effects of PD-L1 on EMT of cancers, showing that STAT1/IFIT2 signaling pathway was required in PD-L1-mediated EMT in human esophageal cancer. Here, STAT1 is linked to cancer.